Bnp Paribas Arbitrage, Snc »

iShares Dow Jones US Pharm Indx shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.3M 100k 72.56
2025-06-30 $13M 200k 65.54

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Meta Platforms Equity (META)
Apple Equity (AAPL)
Tesla Equity (TSLA)
Amazon.com Equity (AMZN)
iShares Core S&P 500 ETF Fund (IVV)
Broadcom Equity (AVGO)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOGL)
SPDR S&P 500 ETF Trust Fund (SPY)
iShares Russell 2000 ETF Fund (IWM)
Alphabet Equity (GOOG)
Cisco Systems Equity (CSCO)
General Electric Equity (GE)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Morgan Stanley
Goldman Sachs Group
LPL Financial
Jpmorgan Chase & Co
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc
Brown Advisory Holdings Incorporated
Raymond James Financial
Concord Investment Counsel
Wells Fargo & Company
UBS Group
Peapack Gladstone Financial Corp
Merit Financial Group
Commonwealth Equity Services

View all funds holding iShares Dow Jones US Pharm Indx